Beta Bionics, Inc.   Report issue

For profit Phase 2 Phase 3
Founded: Boston MA United States (2015)
Status: No NME R&D (2015)

Organization Overview

First Clinical Trial
2016
NCT02971228
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Beta Bionics, Inc.